Literature DB >> 21215479

Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study.

Anna Laura Pasqui, Silvia Maffei, Michela Di Renzo, Gerarda Pompella, Alberto Auteri, Luca Puccetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21215479     DOI: 10.1016/j.ijcard.2010.12.065

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  1 in total

1.  [Pilot study of levosimendan : Effect on liver blood flow and liver function in acute decompensated heart failure].

Authors:  K Lenz; A Gegenhuber; F Firlinger; G Lohr; P Piringer
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-19       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.